Latest reports
116 analyses, newest first.
- Accenture (ACN) · Q1 2026ACN — Q1 FY2026 Financial Report Analysis
Accenture opened fiscal 2026 with revenue up 6% to $18.74 billion and new bookings up 12% to $20.9 billion, but a $308 million severance charge cut reported operating margin to 15.3% and a 290-basis-point jump in the tax rate left GAAP EPS 1% below last year.
- AbbVie (ABBV) · Q1 2026ABBV — Q1 2026 Financial Report Analysis
AbbVie grew revenue 12.4% to $15.0bn and lifted adjusted EPS 7.7% to $2.65, but reported EPS fell 46% to $0.39 on a $2.4bn contingent-consideration charge triggered by its own raised Skyrizi forecast and a $650m RemeGen licence payment.
- Abbott Laboratories (ABT) · Q1 2026ABT — Q1 2026 Financial Report Analysis
Abbott closed its $20.6bn Exact Sciences acquisition eight days before quarter-end, and the deal costs cut GAAP EPS to $0.61 while underlying sales grew just 3.7% — Medical Devices up 8.1% ex-FX against Nutrition down 7.7%.
- A. O. Smith (AOS) · Q1 2026AOS — Q1 2026 Financial Report Analysis
A. O. Smith's Q1 2026 sales fell 1.9% to $945.6M, but currency and the Leonard Valve acquisition masked a ~5% underlying volume decline, and a 17% local-currency drop in China forced a cut to full-year EPS guidance.
- 3M (MMM) · Q1 2026MMM — Q1 2026 Financial Report Analysis
3M reported a 40% drop in GAAP EPS to $1.23 that was driven almost entirely by a $699M non-cash swing in its retained Solventum stake, while adjusted EPS rose 14% to $2.14 and adjusted organic sales grew just 1.2%.
- Microsoft (MSFT) · Q3 2026MSFT — Q3 2026 Financial Report Analysis
With almost no OpenAI accounting effect, Microsoft posted $4.27 diluted EPS on both a reported and adjusted basis as revenue rose 18% to $82.9bn, while gross margin fell 1.1 points and capital spending reached 37% of revenue.
- Microsoft (MSFT) · Q2 2026MSFT — Q2 2026 Financial Report Analysis
Microsoft reported 60% net income growth in the December 2025 quarter, but it came from a $10bn non-cash dilution gain on the OpenAI recapitalisation; adjusted EPS grew 24% while capital spending nearly doubled to $29.9bn.
- Microsoft (MSFT) · Q1 2026MSFT — Q1 2026 Financial Report Analysis
Microsoft opened fiscal 2026 with revenue up 18% to $77.7bn and operating income up 24%, but a $4.1bn non-cash loss on its OpenAI stake held reported EPS growth to 13% against 23% on an adjusted basis.
- Apple Inc. (AAPL) · Q2 2026AAPL — Q2 2026 Financial Report Analysis
Apple posted a record 49.3% gross margin on favorable product mix and a currency tailwind, while the same 10-Q warned that memory and storage component costs are rising and expected to intensify.
- Apple Inc. (AAPL) · Q1 2026AAPL — Q1 2026 Financial Report Analysis
Apple's holiday quarter grew revenue 15.7% to $143.8B, but iPhone supplied about 83% of the increase on a shift toward Pro models, and a higher tax rate held net income growth to 15.9%.
- Albemarle Corporation (ALB) · Q2 2026ALB — Q2 2026 Financial Report Analysis
Albemarle's Q2 2026 sales rose 31% to $1.74 billion and adjusted EBITDA 155% to $858 million, but the revenue bridge shows price added $562 million while volume added only $28 million — a lithium-index recovery on top of a balance sheet cut from $3.1 billion to $1.8 billion of long-term debt.
- Akamai Technologies (AKAM) · Q2 2026AKAM — Q2 2026 Financial Report Analysis
Akamai grew revenue 5% to $1.10 billion as security and cloud infrastructure offset a shrinking CDN business, but GAAP operating income fell 47% on a stock-compensation timing change and network build-out costs, and the company suspended buybacks to fund a $3.5 billion cloud capacity expansion.
- Airbnb (ABNB) · Q2 2026ABNB — Q2 2026 Financial Report Analysis
Airbnb grew Q2 2026 revenue 17% to $3.61B and lifted operating margin to 21.0%, but 27% net income growth shrinks to about 15% once a one-off $77M tax benefit and a 4.6% smaller share count are stripped out.
- Air Products (APD) · Q3 2026APD — Q3 FY2026 Financial Report Analysis
Air Products took a $2.9 billion charge to exit the Louisiana Clean Energy Complex and two other clean-energy projects, swinging to a $6.47 GAAP loss per share, while the underlying industrial gas business raised adjusted EPS 12% to $3.47 and full-year guidance to $13.39-$13.49.
- Agilent Technologies (A) · Q3 2026A — Q3 2026 Financial Report Analysis
Agilent grew revenue 8.1% to $1.88 billion in fiscal Q3 2026 and lifted full-year guidance, but a $20 million tariff refund supplied about a third of the margin expansion and a prior-year tax one-off masks 21% pre-tax profit growth.
- Aflac (AFL) · Q2 2026AFL — Q2 2026 Financial Report Analysis
Aflac's reported profit rose 38% on shrinking investment losses and a 17% tax rate, while adjusted earnings fell 7.7% — a 6.1% smaller share count, not premium growth, is what held EPS roughly flat.
- AES Corporation (AES) · Q2 2026AES — Q2 2026 Financial Report Analysis
AES swung to $387M of net income on 20% revenue growth, but roughly half the improvement came from a $186M Fluence share sale, derivative gains and development fees — all while the company sits under a signed $15.00-per-share take-private by GIP and EQT.
- Advanced Micro Devices (AMD) · Q2 2026AMD — Q2 2026 Financial Report Analysis
AMD grew revenue 50% to a record $11.5 billion as Data Center more than doubled to 58% of the company, but most of the 14-point gross-margin jump is the absence of last year's $800 million China export-control write-off, and Client and Gaming operating profit fell 24%.
- Adobe Inc. (ADBE) · Q3 2026ADBE — Q3 FY2026 Financial Report Analysis
Adobe beat its own Q3 FY2026 guidance with revenue up 12.9% to $6.76 billion and non-GAAP EPS up 15.4% to $6.13, but roughly 2 points of growth came from the Semrush acquisition, a 6.8% smaller share count supplied about half the EPS gain, and the forward gauges — 8.4% RPO growth and an unchanged 10.2% full-year ARR target — all point to deceleration.
- Accenture (ACN) · Q3 2026ACN — Q3 FY2026 Financial Report Analysis
Accenture grew Q3 FY2026 revenue 5.6% to $18.72 billion and EPS 9% to $3.80, but a currency tailwind, a smaller share count and a single region (EMEA) supplied most of the gain while gross margin slipped and bookings fell 3% in local currency.
- AbbVie (ABBV) · Q2 2026ABBV — Q2 2026 Financial Report Analysis
Revenue grew 9.5% on constant currency as Skyrizi and Rinvoq (both +24%) continue to outrun Humira's decline (-36%); GAAP EPS growth of 290% is a base-effect artifact of intangible amortization and contingent-consideration accounting, not operating performance.
- Abbott Laboratories (ABT) · Q2 2026ABT — Q2 2026 Financial Report Analysis
Reported sales grew 13.0% but organic growth was 4.8%; the Exact Sciences acquisition drives most of the gap, and $658M of quarterly intangible amortization plus a $385M litigation reserve explain why GAAP EPS ($0.53) is less than half of adjusted EPS ($1.31).
- A. O. Smith (AOS) · Q2 2026AOS — Q2 2026 Financial Report Analysis
GAAP EPS fell 15%, but a $22.6M one-time restructuring charge accounts for most of the gap to adjusted EPS (-4%); the real story is a genuine 28% China demand decline against +3% organic growth in North America.
- 3M (MMM) · Q2 2026MMM — Q2 2026 Financial Report Analysis
Adjusted organic sales grew 5.4%, but the 33% GAAP EPS growth is mostly one-off items: a $336M divestiture loss, a swing in Solventum stake value, and lower PFAS litigation costs, not operating improvement.
- Microsoft (MSFT) · Full Year 2026MSFT — FY2026 Annual Report Analysis
Revenue grew 18% to $331.8B and Azure crossed $100B for the first time, but roughly a quarter of the 31% GAAP net income growth came from an OpenAI investment swinging from a mark-to-market loss to a gain, not from operations.
- Apple Inc. (AAPL) · Q3 2026AAPL — Q3 2026 Financial Report Analysis
A Pro-model iPhone supercycle drove 16% revenue growth, while R&D spending jumped 32% on explicit AI infrastructure investment — margins expanded even as capex intensity rose.